A20 DUB结构域遗传变异通过上调PADI4促进瓜氨酸化与中性粒细胞胞外诱捕网参与系统性红斑狼疮
该研究利用CRISPR/Cas9构建A20 DUB结构域C103A敲入单核细胞,结合小鼠及rs2230926基因型健康者和SLE患者免疫细胞,发现DUB结构域失活并不增强NF-κB信号,而是上调PADI4、增强蛋白瓜氨酸化和胞外诱捕网形成,且SLE患者rs2230926携带者NETs及抗瓜氨酸化表位抗体频率增加。
要点
- A20 DUB结构域遗传变异不增强NF-κB信号,而是上调PADI4。
- C103A突变或rs2230926多态性增强蛋白瓜氨酸化与胞外诱捕网形成。
- SLE患者rs2230926携带者NETs及抗瓜氨酸化表位抗体频率增加。
核心结论
- A20 DUB结构域遗传变异通过上调PADI4、增强蛋白瓜氨酸化和胞外诱捕网形成,增加SLE易感性。
研究设计与样本
- 使用CRISPR/Cas9构建人U937单核细胞A20 DUB失活C103A敲入突变,并行全基因组RNA测序比较WT与C103A KI细胞差异表达基因。
- 在A20 C103A U937细胞、A20 C103A小鼠免疫细胞及携带A20 DUB多态性rs2230926的健康个体免疫细胞中进行功能研究。
- 在A20 C103A小鼠和携带rs2230926的SLE患者中性粒细胞中离体检测中性粒细胞胞外诱捕网形成。
主要发现
- 人及小鼠髓系细胞中A20 DUB结构域遗传破坏未导致NF-κB信号增强。
- C103A突变或rs2230926多态性细胞中PADI4表达上调。
- A20 C103A细胞显示蛋白瓜氨酸化和胞外诱捕网形成增强,可被选择性PAD4抑制所抑制。
- 携带rs2230926的SLE患者NETs增加,抗瓜氨酸化表位自身抗体频率增加。
临床怎么用
- 对于携带A20 DUB结构域变异(如rs2230926)的SLE患者,可关注NETs及抗瓜氨酸化表位抗体水平。
- 选择性PAD4抑制可能成为针对A20 DUB结构域变异相关SLE病理机制的潜在干预方向。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVES: Genetic variations in TNFAIP3 (A20) de-ubiquitinase (DUB) domain increase the risk of systemic lupus erythematosus (SLE) and rheumatoid arthritis. A20 is a negative regulator of NF-κB but the role of its DUB domain and related genetic variants remain unclear. We aimed to study the functional effects of A20 DUB-domain alterations in immune cells and understand its link to SLE pathogenesis. METHODS: CRISPR/Cas9 was used to generate human U937 monocytes with A20 DUB-inactivating C103A knock-in (KI) mutation. Whole genome RNA-sequencing was used to identify differentially expressed genes between WT and C103A KI cells. Functional studies were performed in A20 C103A U937 cells and in immune cells from A20 C103A mice and genotyped healthy individuals with A20 DUB polymorphism rs2230926. Neutrophil extracellular trap (NET) formation was addressed ex vivo in neutrophils from A20 C103A mice and SLE-patients with rs2230926. RESULTS: Genetic disruption of A20 DUB domain in human and murine myeloid cells did not give rise to enhanced NF-κB signalling. Instead, cells with C103A mutation or rs2230926 polymorphism presented an upregulated expression of PADI4, an enzyme regulating protein citrullination and NET formation, two key mechanisms in autoimmune pathology. A20 C103A cells exhibited enhanced protein citrullination and extracellular trap formation, which could be suppressed by selective PAD4 inhibition. Moreover, SLE-patients with rs2230926 showed increased NETs and increased frequency of autoantibodies to citrullinated epitopes. CONCLUSIONS: We propose that genetic alterations disrupting the A20 DUB domain mediate increased susceptibility to SLE through the upregulation of PADI4 with resultant protein citrullination and extracellular trap formation.
引用
- Odqvist L, Jevnikar Z, Riise R, et al. Genetic variations in A20 DUB domain provide a genetic link to citrullination and neutrophil extracellular traps in systemic lupus erythematosus. Ann Rheum Dis. 2019. PMID: 31300459. doi:10.1136/annrheumdis-2019-215434
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。